User profiles for Leah B. Soriaga
Leah Barrera SoriagaOther name: Leah B. Soriaga Bioinformatics Verified email at perceptrove.com Cited by 17301 |
[HTML][HTML] Lectins enhance SARS-CoV-2 infection and influence neutralizing antibodies
FA Lempp, LB Soriaga, M Montiel-Ruiz, F Benigni… - Nature, 2021 - nature.com
SARS-CoV-2 infection—which involves both cell attachment and membrane fusion—relies
on the angiotensin-converting enzyme 2 (ACE2) receptor, which is paradoxically found at low …
on the angiotensin-converting enzyme 2 (ACE2) receptor, which is paradoxically found at low …
Lipid production in Nannochloropsis gaditana is doubled by decreasing expression of a single transcriptional regulator
I Ajjawi, J Verruto, M Aqui, LB Soriaga… - Nature …, 2017 - nature.com
Lipid production in the industrial microalga Nannochloropsis gaditana exceeds that of
model algal species and can be maximized by nutrient starvation in batch culture. However, …
model algal species and can be maximized by nutrient starvation in batch culture. However, …
Phylogenetic distribution of CRISPR-Cas systems in antibiotic-resistant Pseudomonas aeruginosa
Pseudomonas aeruginosa is an antibiotic-refractory pathogen with a large genome and
extensive genotypic diversity. Historically, P. aeruginosa has been a major model system for …
extensive genotypic diversity. Historically, P. aeruginosa has been a major model system for …
[HTML][HTML] Advances in genomics for drug development
Drug development (target identification, advancing drug leads to candidates for preclinical
and clinical studies) can be facilitated by genetic and genomic knowledge. Here, we review …
and clinical studies) can be facilitated by genetic and genomic knowledge. Here, we review …
[HTML][HTML] Potent broadly neutralizing antibody VIR-3434 controls hepatitis B and D virus infection and reduces HBsAg in humanized mice
…, S Jaconi, L Vincenzetti, H Imam, LB Soriaga… - Journal of …, 2023 - Elsevier
Background & Aims Chronic hepatitis B is a global public health problem, and coinfection
with hepatitis delta virus (HDV) worsens disease outcome. Here, we describe a hepatitis B …
with hepatitis delta virus (HDV) worsens disease outcome. Here, we describe a hepatitis B …
[PDF][PDF] Antibody therapy reverses biological signatures of COVID-19 progression
Understanding who is at risk of progression to severe coronavirus disease 2019 (COVID-19)
is key to clinical decision making and effective treatment. We study correlates of disease …
is key to clinical decision making and effective treatment. We study correlates of disease …
Antibody therapy reverses biological signatures of COVID-19 progression (preprint)
MC Maher, LB Soriaga, A Gupta, J di Iulio, S Ledoux… - 2021 - pesquisa.bvsalud.org
Understanding who is at risk of progression to severe COVID-19 is key to effective treatment.
We studied correlates of disease severity in the COMET-ICE clinical trial that randomized …
We studied correlates of disease severity in the COMET-ICE clinical trial that randomized …
Electrochemical atomic layer deposition (E-ALD) of palladium nanofilms by surface limited redox replacement (SLRR), with EDTA complexation
…, JL Stickney, DB Robinson, MP Soriaga - Electrocatalysis, 2012 - Springer
Atomic-scale control in the formation of Pd thin films is being developed using electrochemical
atomic layer deposition (E-ALD) via surface limited redox replacement (SLRR). Pd has …
atomic layer deposition (E-ALD) via surface limited redox replacement (SLRR). Pd has …
Imprinted antibody responses against SARS-CoV-2 Omicron sublineages
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron sublineages carry
distinct spike mutations resulting in escape from antibodies induced by previous infection or …
distinct spike mutations resulting in escape from antibodies induced by previous infection or …
[CITATION][C] Phylogenetic distribution of CRISPR-Cas systems in antibiotic-resistant Pseudomonas aeruginosa. mBio 6: e01796-15
A van Belkum, LB Soriaga, MC LaFave, S Akella… - 2015 - November